Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Lamedica AB
AB
Active
Org 5593922072
Fyrspannsvägen 164
Retail sale of pharmaceutical products · NACE 4773
Est. 2022
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 0
EBITDA margin
—
-101% vs 2024
Equity ratio
70.9%
Financial strength
Net profit 2025
SEK -15K
-102% vs 2024
EBITDA — year on year
SEK millions
1M
1M
1M
0M
0M
1M
2023
1M
0%
2024
0M
-100%
2025
Key figures
Annual report 2025
Revenue
SEK 0
—
EBITDA
SEK -12K
-101%
Net profit
SEK -15K
-102%
Total assets
SEK 1,5M
-30%
Equity
SEK 1,1M
-1%
Employees
1
—
Company information
Legal name
Lamedica AB
Org number
5593922072
Legal form
Aktiebolag
NACE code
4773 · Retail sale of pharmaceutical products
Founded
11 augusti 2022
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva apoteks- och hälsokostverksamhet och därmed sammanhörande verksamheter.
Contact
Address
Fyrspannsvägen 164
Email
info@hasselbyapotek.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of pharmaceutical products
Companies in Stockholm
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2023
1M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2023
1M
2024
0M
2025
Income statement
SEK thousands
Item
2023
2024
2025
Revenue
700
1 200
0
Staff expenses
−105
−26
−0
EBITDA
592
1 165
−12
Depreciation & amort.
—
—
—
EBIT
592
1 165
−12
Net financials
−1
−0
−3
Profit before tax
447
875
−15
Tax
−92
−181
—
Net profit
354
694
−15
Balance sheet
SEK thousands
Item
2023
2024
2025
Total assets
751
2 129
1 494
Equity
379
1 073
1 059
Long-term debt
—
—
—
Short-term debt
227
620
0
Total debt
227
620
—
Financial ratios
5-year trend
EBITDA margin
-1154300.0%
This company
15.8%
Market median
-7305796% vs market
2023
2025
Equity ratio
70.9%
This company
38.2%
Market median
+86% vs market
2023
2025
Return on equity
-1.4%
This company
18.4%
Market median
-108% vs market
2023
2025
Net profit margin
-1488000.0%
This company
8.1%
Market median
-18370470% vs market
2023
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2023
2025
Debt / equity
0.41×
This company
0.62×
Market median
+34% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-08-11 – 2023-04-30
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
LT
Lana Toffik Arif
Deputy Board Member
2022
FT
Fatah Toffik Arif
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Lamedica AB also hold positions in
0
other companies.
Person
Role here
Other companies
Lana Toffik Arif
Deputy Board Member
0 companies
Fatah Toffik Arif
Board of Directors
0 companies